EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cartilage organoids: an emerging platform for novel osteoarthritis therapies

Bimin Gao, Zecai Chen, Yufeng Long, Feng He, Donghao Gan, Weihong Yi, Guozhi Xiao, Jiangdong Ren, Lei Qin

Frontiers in Cell and Developmental Biology · 12.12.2025 · 13

DOI: 10.3389/fcell.2025.1668766 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 12.12.2025. Verfasst von Bimin Gao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Orthopaedic Innovation Laboratory, Shenzhen Nanshan People's Hospital, The Affiliated Nanshan Hospital of Shenzhen University, Shenzhen, Guangdong, C…. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 147 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoarthritis (OA) is a chronic, multifactorial joint disorder characterized by the progressive degeneration and dysfunction of various joint tissues. Current treatments primarily focus on symptom management, offering limited success in halting cartilage degradation or repairing damaged tissues. Consequently, there is a pressing need for innovative therapeutic strategies aimed at cartilage regeneration and structural repair. Over the past 2 decades, cartilage organoids have emerged as a promising alternative for OA treatment. Due to their unique regenerative properties, cartilage organoids provide a versatile platform for various applications in OA research and therapy, including in vitro disease modeling, drug screening, regenerative medicine, and biomechanical studies. This review summarizes current research progress and insights into OA pathogenesis and therapeutic approaches, explores the development of cartilage organoid technologies with a focus on organoid constructions and different methodologies, and discusses the future applications of cartilage organoids as essential in vitro models for drug screening and personalized therapies for OA studies and treatment.

Schlagwörter

Stichwörter der Autor:innen

cartilage organoidsdrug screeningin vitro modelsosteoarthritispersonalized therapies

Autor:innen und Institutionen

  • Orthopaedic Innovation Laboratory, Shenzhen Nanshan People's Hospital, The Affiliated Nanshan Hospital of Shenzhen University, Shenzhen, Guangdong, China.
  • Department of Osteoarthropathy, Shenzhen Nanshan People's Hospital, Shenzhen, Guangdong, China.
  • Department of Spine Surgery, Shenzhen Nanshan People's Hospital, Shenzhen, Guangdong, China.
  • Department of Orthopaedics and Rehabilitation, Yale University School of Medicine, New Haven, CT, United States.
  • Department of Biochemistry, Homeostatic Medicine Institute, School of Medicine, Guangdong Provincial Key Laboratory of Cell Microenvironment and Disease Research, Shenzhen Key Laboratory of Cell Microenvironment, Southe…

Zitieren

APA

Gao, B., Chen, Z., Long, Y., He, F., Gan, D., Yi, W., Xiao, G., Ren, J., & Qin, L. (2025). Cartilage organoids: an emerging platform for novel osteoarthritis therapies. Frontiers in Cell and Developmental Biology, 13. https://doi.org/10.3389/fcell.2025.1668766

Vancouver

Gao B, Chen Z, Long Y, He F, Gan D, Yi W, et al. Cartilage organoids: an emerging platform for novel osteoarthritis therapies. Frontiers in Cell and Developmental Biology. 2025;13. doi:10.3389/fcell.2025.1668766

BibTeX
@article{Gao2025,
  author = {Gao, Bimin and Chen, Zecai and Long, Yufeng and He, Feng and Gan, Donghao and Yi, Weihong and Xiao, Guozhi and Ren, Jiangdong and Qin, Lei},
  title = {Cartilage organoids: an emerging platform for novel osteoarthritis therapies},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2025},
  volume = {13},
  doi = {10.3389/fcell.2025.1668766}
}
Kostenlos starten →